These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1706 related articles for article (PubMed ID: 22410070)

  • 1. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.
    Nakamura Y; Hama K; Iwamoto H; Yokoyama T; Kihara Y; Konno O; Jojima Y; Shimazu M
    Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABO-incompatible adult living donor liver transplantation for hepatocellular carcinoma.
    Matsuno N; Iwamoto H; Nakamura Y; Hama K; Kihara Y; Konno O; Jojima Y; Akashi I; Mijiti A; Ashizawa T; Nagao T
    Transplant Proc; 2008 Oct; 40(8):2497-500. PubMed ID: 18929778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up ABO-incompatible adult living donor liver transplantation in cirrhotic patients.
    Matsuno N; Nakamura Y; Mejit A; Hama K; Iwamoto H; Konno O; Jojima Y; Akashi I; Iwahori T; Ashizawa T; Nagao T
    Clin Transplant; 2007; 21(5):638-42. PubMed ID: 17845639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful case of adult ABO-incompatible liver transplantation: beneficial effects of intrahepatic artery infusion therapy: a case report.
    Nakamura Y; Matsuno N; Iwamoto H; Yokoyama T; Kuzuoka K; Kihara Y; Taira S; Sagara T; Jojima Y; Konno O; Tashiro J; Akashi I; Hama K; Narumi K; Iwahori T; Uchiyama M; Tanaka K; Nagao T
    Transplant Proc; 2004 Oct; 36(8):2269-73. PubMed ID: 15561215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
    Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
    Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation.
    Ashizawa T; Matsuno N; Yokoyama T; Kihara Y; Kuzuoka K; Taira S; Konno O; Jyojima Y; Akashi I; Nakamura Y; Hama K; Iwamoto H; Iwahori T; Nagao T; Kasahara M; Tanaka K
    Transplant Proc; 2006 Dec; 38(10):3629-32. PubMed ID: 17175351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of high-dose mizoribine in ABO-incompatible kidney transplantation using anti-CD20 and anti-CD25 antibody without splenectomy treatment.
    Yoshimura N; Ushigome H; Matsuyama M; Nobori S; Suzuki T; Sakai K; Okajima H; Okamoto M
    Transplant Proc; 2012 Jan; 44(1):140-3. PubMed ID: 22310599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO-incompatible living donor liver transplantation without graft local infusion and splenectomy.
    Lee SD; Kim SH; Kong SY; Kim YK; Lee SA; Park SJ
    HPB (Oxford); 2014 Sep; 16(9):807-13. PubMed ID: 24467804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
    Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
    J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The excellent outcomes of ABO-incompatible kidney transplantation with high titer (>×2048) using anti-CD20 and anti-CD25 antibody without splenectomy: two case reports.
    Koshino K; Okamoto M; Sakai K; Suzuki T; Nobori S; Matsuyama M; Ushigome H; Okajima H; Yoshimura N
    Transplant Proc; 2011; 43(6):2379-82. PubMed ID: 21839272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult ABO-incompatible liver transplantation, using A and B donors.
    Skogsberg U; Breimer ME; Friman S; Mjörnstedt L; Mölne J; Olausson M; Rydberg L; Svalander CT; Bäckman L
    Xenotransplantation; 2006 Mar; 13(2):154-9. PubMed ID: 16623811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of intraportal donor-specific leukocyte transfusion for adult ABO-incompatible liver transplantation.
    Oya H; Sato Y; Yamamoto S; Nakatsuka H; Kobayashi T; Watanabe T; Hara Y; Kokai H; Hatakeyama K
    Transplant Proc; 2009; 41(1):222-5. PubMed ID: 19249519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of apheresis therapy for ABO incompatible living donor liver transplantation: the Kyoto University experience.
    Kozaki K; Egawa H; Ueda M; Oike F; Yoshizawa A; Fukatsu A; Takada Y
    Ther Apher Dial; 2006 Oct; 10(5):441-8. PubMed ID: 17096700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful long-term outcome of ABO-incompatible liver transplantation using antigen-specific immunoadsorption columns.
    Saliba F; Ichaï P; Azoulay D; Habbouchi H; Antonini T; Sebagh M; Adam R; Castaing D; Samuel D
    Ther Apher Dial; 2010 Feb; 14(1):116-23. PubMed ID: 20438529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful liver transplantation across the ABO incompatibility barrier in 6 cases of biliary atresia.
    Yamada Y; Hoshino K; Morikawa Y; Okamura J; Hotta R; Komori K; Nakao S; Obara H; Kawachi S; Fuchimoto Y; Tanabe M; Shimazu M; Kitajima M
    J Pediatr Surg; 2006 Dec; 41(12):1976-9. PubMed ID: 17161185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab.
    Raut V; Mori A; Kaido T; Ogura Y; Taku I; Nagai K; Sasaki N; Endo K; Hata T; Yagi S; Egawa H; Uemoto S
    Transplantation; 2012 Jan; 93(1):99-105. PubMed ID: 22094955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepancy of B cell frequency between periphery and spleen after rituximab treatment in ABO-incompatible liver transplantation.
    Iso Y; Sawada T; Kita J; Shiraki T; Sakuraoka Y; Kato M; Shimoda M; Kubota K
    Hepatogastroenterology; 2013 Oct; 60(127):1624-6. PubMed ID: 24634932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.
    Faria LC; Gigou M; Roque-Afonso AM; Sebagh M; Roche B; Fallot G; Ferrari TC; Guettier C; Dussaix E; Castaing D; Brechot C; Samuel D
    Gastroenterology; 2008 Jun; 134(7):1890-9; quiz 2155. PubMed ID: 18424269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation.
    Takahashi K; Saito K; Takahara S; Fuchinoue S; Yagisawa T; Aikawa A; Watarai Y; Yoshimura N; Tanabe K; Morozumi K; Shimazu M;
    Clin Exp Nephrol; 2017 Aug; 21(4):705-713. PubMed ID: 27534951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First two ABO-incompatible living renal transplantations using splenectomy, rituximab, plasmapheresis and IVIG as a preconditioning regimen: a single center experience in the Balkans.
    Ivanovski N; Popov Z; Masin-Spasovska J; Dimcevska AH; Kolevski P
    Xenotransplantation; 2006 Mar; 13(2):123-5. PubMed ID: 16623805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 86.